Oncology Institute, Inc.
ent_019ed2ae9b84aa1b4967019b7c59043d
Disclosures
2
SEC 8-K · SEC 10-K Item 1C · 1 jurisdiction
Incidents
—
no linked incident in sample
Max affected reported
—
no filed count in sample
Leak-site claims
0
none in sample
Identity resolution
- Canonical name
- Oncology Institute, Inc.
- Normalized
- oncology institute— dedupe via name-norm; Microsoft / MSFT collapse to one row
- GLEIF LEI
- No match
- SEC EDGAR CIK
- 0001799191
- Domain
- None on record
Disclosure history (2)newest first
- FEDERALSEC 8-Kas victim2026-05-22
The Oncology Institute, Inc. filed an Item 1.05 8-K supplementing its November 6, 2025 voluntary 7.01 disclosure regarding a cybersecurity incident at a software service provider (Vendor). On May 20, 2026, Kroll, the Vendor's third-party administrator, notified the Company that an unauthorized third party had accessed certain Company information systems, including systems containing patient data. The Company states operations continued in all material respects and it will work with the Vendor to offer credit monitoring to impacted patients.
- FEDERALSEC 10-K Item 1Cas victim2026-03-12
The Company (a healthcare IT entity) disclosed a cybersecurity incident involving a third-party software provider on November 3, 2025. The incident caused a brief, immaterial delay in fee-for-service collections. No evidence of patient personal information compromise was found, though investigation is ongoing. Normal billing operations were restored.